{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T07:45:22Z","timestamp":1772783122913,"version":"3.50.1"},"reference-count":35,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100008476","name":"University of California Irvine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008476","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jvir.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Vascular and Interventional Radiology"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.jvir.2025.08.005","type":"journal-article","created":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T05:50:47Z","timestamp":1754891447000},"page":"1687-1695","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Pilot Study of Combining Stereotactic Body Radiation Therapy with Pulsed Field Ablation for Oligometastatic\/Oligoprogressive Lung Tumors"],"prefix":"10.1016","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7603-0263","authenticated-orcid":false,"given":"Jeremy P.","family":"Harris","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christina","family":"Boyd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mengying","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2481-6728","authenticated-orcid":false,"given":"Michael","family":"Reilly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4685-2711","authenticated-orcid":false,"given":"Aaron","family":"Simon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven N.","family":"Seyedin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen-Pin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Misako","family":"Nagasaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rupali","family":"Nabar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6163-8524","authenticated-orcid":false,"given":"Nadine","family":"Abi-Jaoudeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jvir.2025.08.005_bib1","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1016\/S1470-2045(16)30532-0","article-title":"Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic therapy: a multicentre, randomised, controlled, phase 2 study","volume":"17","author":"Gomez","year":"2016","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jvir.2025.08.005_bib2","doi-asserted-by":"crossref","first-page":"2830","DOI":"10.1200\/JCO.20.00818","article-title":"Stereotactic ablative radiotherapy for the comprehensive treatment of oligometastatic cancers: long-term results of the SABR-COMET phase ii randomized trial","volume":"38","author":"Palma","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jvir.2025.08.005_bib3","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0140-6736(23)01857-3","volume":"403","author":"Tsai","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.jvir.2025.08.005_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2025.104676","article-title":"Consolidative radiotherapy in oligometastatic and oligoprogressive NSCLC: a systematic review","volume":"210","author":"Hasan","year":"2025","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.jvir.2025.08.005_bib5","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.21037\/jtd-21-1824","article-title":"A guide for managing patients with stage I NSCLC: deciding between lobectomy, segmentectomy, wedge, SBRT and ablation\u2014part 2: systematic review of evidence regarding resection extent in generally healthy patients","volume":"14","author":"Detterbeck","year":"2022","journal-title":"J Thorac Dis"},{"key":"10.1016\/j.jvir.2025.08.005_bib6","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1016\/j.jtho.2019.04.018","article-title":"Safety and effectiveness of stereotactic ablative radiotherapy for ultra-central lung lesions: a systematic review","volume":"14","author":"Chen","year":"2019","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jvir.2025.08.005_bib7","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1200\/JCO.18.00622","article-title":"Safety and efficacy of a five-fraction stereotactic body radiotherapy schedule for centrally located non-small-cell lung cancer: NRG oncology\/RTOG 0813 Trial","volume":"37","author":"Bezjak","year":"2019","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jvir.2025.08.005_bib8","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/j.jtho.2021.03.019","article-title":"The HILUS-trial\u2014a prospective Nordic multi-center phase II study of ultra-central lung tumors treated with stereotactic body radiotherapy","volume":"16","author":"Lindberg","year":"2021","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jvir.2025.08.005_bib9","doi-asserted-by":"crossref","first-page":"316","DOI":"10.5152\/dir.2014.13440","article-title":"Tatltljtho.2021.03.019r phase II study of ultra-central lung tumors treated with stereotactic body radiDiagn","volume":"20","author":"Colak","year":"2014","journal-title":"Interv Radiol"},{"key":"10.1016\/j.jvir.2025.08.005_bib10","series-title":"Clinical aspects of electroporation","first-page":"9","article-title":"Electroporation and cellular physiology","author":"Gissel","year":"2011"},{"key":"10.1016\/j.jvir.2025.08.005_bib11","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.jvir.2010.12.014","article-title":"Investigation of the safety of irreversible electroporation in humans","volume":"22","author":"Thomson","year":"2011","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.jvir.2025.08.005_bib12","doi-asserted-by":"crossref","first-page":"CS43","DOI":"10.12659\/MSM.882888","article-title":"Irreversible electroporation of lung neoplasm: a case series","volume":"18","author":"Usman","year":"2012","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.jvir.2025.08.005_bib13","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s00270-014-1049-0","article-title":"Irreversible electroporation of lung neoplasm: a case series. erapy. tectomy, wedge, SBR II trial on lung malignancies: the ALICE trial","volume":"38","author":"Ricke","year":"2015","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.jvir.2025.08.005_bib14","doi-asserted-by":"crossref","first-page":"S71","DOI":"10.1016\/j.jvir.2022.12.207","article-title":"Abstract No. 153 single-needle delivery of pulsed electric fields (PEF) energy to early-stage non- small cell lung cancer (NSCLC): feasibility and safety near sensitive structures in the INCITE ES study","volume":"34","author":"Jimenez","year":"2023","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.jvir.2025.08.005_bib15","article-title":"702 Tertiary lymphoid structures (TLS) observed in non-small cell lung cancer (NSCLC) tumors treated with pulsed electric fields","volume":"10","author":"Iding","year":"2022","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.jvir.2025.08.005_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.lungcan.2025.108575","article-title":"Early experience with PEF in the setting of recalcitrant stage IV lung cancer","volume":"204","author":"Moore","year":"2025","journal-title":"Lung Cancer"},{"key":"10.1016\/j.jvir.2025.08.005_bib17","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.jvir.2024.10.033","article-title":"Limited effectiveness in early human clinical experience with pulsed electrical field ablation","volume":"36","author":"Rouhezamin","year":"2025","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.jvir.2025.08.005_bib18","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0005-2736(99)00154-6","article-title":"The generation of reactive-oxygen species associated with long-lasting pulse-induced electropermeabilisation of mammalian cells is based on a non-destructive alteration of the plasma membrane","volume":"1461","author":"Bonnafous","year":"1999","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.jvir.2025.08.005_bib19","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1615\/JEnvironPatholToxicolOncol.v24.i4.60","article-title":"Enhancement of radiation cytotoxicity in murine cancer cells by electroporation: in vitro and in vivo studies","volume":"24","author":"Shil","year":"2005","journal-title":"J Environ Pathol Toxicol Oncol"},{"key":"10.1016\/j.jvir.2025.08.005_bib20","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/S1470-2045(08)70155-4","article-title":"Response to radiofrequency ablation of pulmonary tumours: a prospective, intention-to-treat, multicentre clinical trial (the RAPTURE study)","volume":"9","author":"Lencioni","year":"2008","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jvir.2025.08.005_bib21","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/j.jtho.2020.02.022","article-title":"Multicenter Study of Metastatic Lung Tumors Targeted by Interventional Cryoablation Evaluation (SOLSTICE)","volume":"15","author":"Callstrom","year":"2020","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jvir.2025.08.005_bib22","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1378\/chest.129.3.738","article-title":"Radiofrequency ablation followed by conventional radiotherapy for medically inoperable stage I non-small cell lung cancer","volume":"129","author":"Dupuy","year":"2006","journal-title":"Chest"},{"key":"10.1016\/j.jvir.2025.08.005_bib23","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/j.jtho.2024.05.366","article-title":"Stereotactic body radiotherapy for centrally located inoperable early-stage NSCLC: EORTC 22113 LungTech phase II trial results","volume":"19","author":"Levy","year":"2024","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jvir.2025.08.005_bib24","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.ijrobp.2024.03.050","article-title":"Stereotactic radiation for ultra-central non-small cell lung cancer: a safety and efficacy trial (SUNSET)","volume":"120","author":"Meredith","year":"2024","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"25","key":"10.1016\/j.jvir.2025.08.005_bib25","first-page":"00096","article-title":"The impact of ultracentral tumor location on outcomes in patients with pulmonary oligometastases: a secondary analysis of the single-arm phase 2 SABR-5 trial","volume":"S0360-3016","author":"Baker","year":"2025","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.jvir.2025.08.005_bib26","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1001\/jamaoncol.2018.1258","article-title":"Long-term results of stereotactic body radiation therapy in medically inoperable stage I non-small cell lung cancer","volume":"4","author":"Timmerman","year":"2018","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.jvir.2025.08.005_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2023.109697","article-title":"A competing risk analysis of the patterns and risk factors of recurrence in early-stage non-small cell lung cancer treated with stereotactic ablative radiotherapy","volume":"185","author":"Tonneau","year":"2023","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.jvir.2025.08.005_bib28","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1016\/j.jtho.2021.07.021","article-title":"The ECLIPSE study: efficacy of cryoablation on metastatic lung tumors with a 5-year follow-up","volume":"16","author":"de Ba\u00e8re","year":"2021","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jvir.2025.08.005_bib29","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.ijrobp.2018.03.011","article-title":"A prospective phase 2 study evaluating safety and efficacy of combining stereotactic body radiation therapy with heat-based ablation for centrally located lung tumors","volume":"101","author":"Sandler","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.jvir.2025.08.005_bib30","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s10439-005-8981-8","article-title":"Tissue ablation with irreversible electroporation","volume":"33","author":"Davalos","year":"2005","journal-title":"Ann Biomed Eng"},{"key":"10.1016\/j.jvir.2025.08.005_bib31","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1080\/09553009214551011","article-title":"A potential pitfall in the use of electroporation: cellular radiosensitization by pulsed high-voltage electric fields","volume":"61","author":"West","year":"1992","journal-title":"Int J Radiat Biol"},{"key":"10.1016\/j.jvir.2025.08.005_bib32","first-page":"1259","article-title":"Radiotherapy enhancement with electroporation in human intestinal colon cancer HT-29 cells","volume":"19","author":"Yadollahpour","year":"2018","journal-title":"Asian Pac J Cancer Prev"},{"key":"10.1016\/j.jvir.2025.08.005_bib33","doi-asserted-by":"crossref","first-page":"67","DOI":"10.2478\/v10019-010-0025-9","article-title":"Radiotherapy in combination with vascular-targeted therapies","volume":"44","author":"Ciric","year":"2010","journal-title":"Radiol Oncol"},{"key":"10.1016\/j.jvir.2025.08.005_bib34","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/S0360-3016(99)00464-2","article-title":"Improvement of combined modality therapy with cisplatin and radiation using electroporation of tumors","volume":"46","author":"Sersa","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.jvir.2025.08.005_bib35","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/1471-2407-5-115","article-title":"Radiosensitising effect of electrochemotherapy with bleomycin in LPB sarcoma cells and tumors in mice","volume":"5","author":"Kranjc","year":"2005","journal-title":"BMC Cancer"}],"container-title":["Journal of Vascular and Interventional Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1051044325005159?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1051044325005159?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T01:45:56Z","timestamp":1761183956000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1051044325005159"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":35,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S1051044325005159"],"URL":"https:\/\/doi.org\/10.1016\/j.jvir.2025.08.005","relation":{},"ISSN":["1051-0443"],"issn-type":[{"value":"1051-0443","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pilot Study of Combining Stereotactic Body Radiation Therapy with Pulsed Field Ablation for Oligometastatic\/Oligoprogressive Lung Tumors","name":"articletitle","label":"Article Title"},{"value":"Journal of Vascular and Interventional Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jvir.2025.08.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 SIR, 2025","name":"copyright","label":"Copyright"}]}}